Ligand Pharmaceuticals LGND
NASDAQ LGND
$308.08 -2.28 (-0.74%)
As of: Sep 30, 2026 · 9:41 AM EDT

Ligand Pharmaceuticals (LGND) Non-Current Assets (2010 - 2026)

Updated

Ligand Pharmaceuticals' Non-Current Assets came in at $728.76 million for Q2 2026, up 22.3% from $595.66 million a year earlier and up 9.3% from the prior quarter.

Analysis

Ligand Pharmaceuticals (LGND) Non-Current Assets (2010 - 2026) Analysis & Trends

At the end of FY2025, Ligand Pharmaceuticals' Non-Current Assets was $728.37 million, up 19.4% from FY2024.

  • Non-Current Assets has increased in each of the last three years, though with a five-year compound annual growth rate of -3.3% (FY2020 to FY2025).
  • Going back by year, Non-Current Assets was $610.22 million in FY2024 (+11.0%), $549.79 million in FY2023 (+10.2%), $499.07 million in FY2022 (-40.1%) and $832.84 million in FY2021 (-3.4%).
  • The Q2 2026 figure represents the highest quarterly Non-Current Assets since Q3 2022.
  • Year-over-year, Non-Current Assets has increased for 11 consecutive quarters, with growth averaging 14.8% over the last eight quarters.
  • The fastest year-over-year change in Non-Current Assets over five years came in Q3 2021 (growth of 115.9%), and the weakest in Q2 2023 (a decline of 42.2%).
  • Business Quant data shows LGND's Non-Current Assets at $666.69 million (Q1 2026), $728.37 million (Q4 2025) and $722.85 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 141.29 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 101.45 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 125.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 94.68 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 87.87 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 60.68 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 35.42 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 159.77 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 14.88 Bn
10 Ligand Pharmaceuticals 6.26 Bn 2.72 Bn - 728.76 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 728.76 Mn
Mar 31, 2026 666.69 Mn
Dec 31, 2025 728.37 Mn
Sep 30, 2025 722.85 Mn
Jun 30, 2025 595.66 Mn
Mar 31, 2025 596.12 Mn
Dec 31, 2024 610.22 Mn
Sep 30, 2024 645.48 Mn
Jun 30, 2024 554.15 Mn
Mar 31, 2024 544.96 Mn
Dec 31, 2023 549.79 Mn
Sep 30, 2023 515.23 Mn
Jun 30, 2023 481.39 Mn
Mar 31, 2023 482.88 Mn
Dec 31, 2022 499.07 Mn
Sep 30, 2022 830.17 Mn
Jun 30, 2022 832.50 Mn
Mar 31, 2022 829.12 Mn
Dec 31, 2021 832.84 Mn
Sep 30, 2021 841.57 Mn
API Access

Ligand Pharmaceuticals Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=LGND&period=max&api_key=YOUR_API_KEY